Stephens Consulting, LLC Royalty Pharma PLC Transaction History
Stephens Consulting, LLC
- $422 Billion
- Q2 2025
A detailed history of Stephens Consulting, LLC transactions in Royalty Pharma PLC stock. As of the latest transaction made, Stephens Consulting, LLC holds 20 shares of RPRX stock, worth $742. This represents 0.0% of its overall portfolio holdings.
Number of Shares
20Holding current value
$742% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding RPRX
# of Institutions
498Shares Held
288MCall Options Held
2.51MPut Options Held
940K-
Morgan Stanley New York, NY41MShares$1.52 Billion0.09% of portfolio
-
Vanguard Group Inc Valley Forge, PA36.7MShares$1.36 Billion0.02% of portfolio
-
Black Rock Inc. New York, NY23MShares$854 Million0.01% of portfolio
-
Baillie Gifford & CO18MShares$669 Million0.51% of portfolio
-
Swedbank Ab Stockholm, V712.2MShares$451 Million0.51% of portfolio
About Royalty Pharma plc
- Ticker RPRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 437,139,008
- Market Cap $16.2B
- Description
- Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic i...